TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that Alan W. Dunton, M.D., has been appointed to the Company’s Board of Directors and named Non-Executive Chairman, effective immediately. Dr. Dunton replaces Bob Savage in this role, who remains on the Board as a Director. With the addition of Dr. Dunton, EpiCept’s Board has seven Directors.
